XML 50 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Sales by Significant Product Group
The following table presents information about our reportable segments, reconciled to consolidated totals:
Three Months Ended
September 30,		Nine Months Ended
September 30,
($ in millions)2025202420252024
Net sales:    
Proprietary Products$647.5 $601.4 $1,830.3 $1,720.6 
Contract-Manufactured Products157.1 145.5 438.8 423.8 
Consolidated net sales$804.6 $746.9 $2,269.1 $2,144.4 
Schedule of Segment Reporting Information, by Segment
The following tables provide summarized financial information for our two reportable segments and corporate and unallocated:
($ in millions)September 30,
2025		December 31,
2024
Assets
Proprietary Products$2,989.3 $2,621.1 
Contract-Manufactured Products685.9 612.2 
Corporate and Unallocated (1)
430.6 410.1 
Total consolidated$4,105.8 $3,643.4 
(1) Corporate and unallocated assets primarily include investments in affiliated companies, cash and cash equivalents, property, plant and equipment used in our corporate operations and deferred income taxes.
($ in millions)Three Months Ended
September 30,		Nine Months Ended
September 30,
Depreciation and Amortization2025202420252024
Proprietary Products$35.1 $33.8 $101.5 $96.8 
Contract-Manufactured Products7.1 5.5 20.3 15.1 
Corporate and Unallocated0.8 0.9 2.6 2.8 
Total consolidated$43.0 $40.2 $124.4 $114.7 
($ in millions)Three Months Ended
September 30,		Nine Months Ended
September 30,
Capital Expenditures2025202420252024
Proprietary Products$47.7 $47.8 $148.1 $167.4 
Contract-Manufactured Products13.6 30.0 57.2 96.8 
Corporate and Unallocated2.0 3.5 4.5 7.9 
Total consolidated$63.3 $81.3 $209.8 $272.1 
The following table provides summarized financial information for our segments:

Three months ended September 30, 2025Three months ended September 30, 2024
($ in millions)Proprietary ProductsContract-Manufactured ProductsTotalProprietary ProductsContract-Manufactured ProductsTotal
Net sales$647.5 $157.1 $804.6 $601.4 $145.5 $746.9 
Cost of goods and services sold383.5 126.8 365.7 116.5 
Research and development17.1 — 15.5 — 
Selling, general and administrative expenses65.6 7.5 56.6 6.7 
Other segment expense (income)(4)
6.1 0.5 5.4 0.5 
Segment operating profit$175.2 $22.3 $197.5 $158.2 $21.8 $180.0 
Reconciliation of profit or loss:
Stock-based compensation(8.4)(5.1)
Corporate general costs(1)
(19.0)(14.3)
Unallocated items:
Restructuring and related charges(2)
(2.5)0.9 
Amortization of acquisition-related intangible assets(3)
— (0.2)
Total consolidated operating profit167.6 161.3 
Interest (income) expense and other nonoperating expense (income), net(4.3)(3.2)
Income before income taxes and equity in net income of affiliated companies$171.9 $164.5 
Nine Months Ended September 30, 2025Nine months ended September 30, 2024
($ in millions)Proprietary ProductsContract-Manufactured ProductsTotalProprietary ProductsContract-Manufactured ProductsTotal
Net sales$1,830.3 $438.8 $2,269.1 $1,720.6 $423.8 $2,144.4 
Cost of goods and services sold1,107.8 361.2 1,070.8 348.7 
Research and development52.5 — 50.6 — 
Selling, general and administrative expenses187.4 22.1 173.4 19.1 
Other segment expense (income)(4)
15.1 1.9 10.3 (0.1)
Segment operating profit$467.5 $53.6 $521.1 $415.5 $56.1 $471.6 
Reconciliation of profit or loss:
Stock-based compensation(17.1)(14.4)
Corporate general costs(1)
(53.6)(47.2)
Unallocated items:
Restructuring and related charges(2)
(21.9)0.9 
Amortization of acquisition-related intangible assets(3)
(0.2)(0.6)
Total consolidated operating profit428.3 410.3 
Interest (income) expense and other nonoperating expense (income), net(11.1)(10.3)
Income before income taxes and equity in net income of affiliated companies$439.4 $420.6 
(1) Corporate general costs includes executive and director compensation, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments.
(2) During the three and nine months ended September 30, 2025, the Company recorded charges of $2.5 million and $21.9 million, respectively, related to restructuring programs. The Company recorded $0.9 million and $17.5 million in the three and nine months ended September 30, 2025, respectively, of these charges within other expense (income), related to severance and acceleration of depreciation and lease costs in connection with the Company's 2025 restructuring plan. The remaining $1.6 million and $4.4 million, respectively, of expense, recorded within selling, general and administrative expenses, relates to our plan to optimize the legal structure of the Company and its subsidiaries. Restructuring and other charges were a net benefit of $0.9 million for the three and nine months ended September 30, 2024. The net benefit represented the impact of two items, the first of which is a $2.5 million benefit recorded within other expense (income) related to revised severance estimates in connection with the Company's 2022 restructuring plan. This benefit was partially offset by $1.6 million of expense recorded within selling, general and administrative expenses, related to our plan to optimize the legal structure of the Company and its subsidiaries. Please refer to Note 14, Other Expense (Income), for further discussion of this item.
(3) During the three and nine months ended September 30, 2025 and 2024, we recorded $0.0 million and $0.2 million, and $0.2 million and $0.6 million, respectively, of amortization expense within operating profit associated with an intangible asset acquired during the second quarter of 2020.
(4) Other segment expense (income) primarily includes foreign exchange transaction gains and losses, adjustments to contingent consideration and asset impairments attributable to the segments during the three and nine months ended September 30, 2025 and 2024.